Skip Navigation

Cardiovascular Research 2007 73(4):689-698; doi:10.1016/j.cardiores.2006.12.003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vila-Petroff, M.
Right arrow Articles by Mattiazzi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vila-Petroff, M.
Right arrow Articles by Mattiazzi, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia–reperfusion injury

Martin Vila-Petroffa,1, Margarita A. Salasa,1, Matilde Saida, Carlos A. Valverdea, Luciana Sapiaa, Enrique Portianskyb, Roger J. Hajjarc, Evangelia G. Kraniasd, Cecilia Mundiña-Weilenmanna,* and Alicia Mattiazzia,*

aCentro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, 60 y 120, (1900) La Plata, Argentina
bDepartamento de Patología, Facultad de Veterinaria, La Plata, Argentina
cCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA
dDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575, USA

* Corresponding authors. Tel./fax: +54 221 483 4833. Email address: cmundweil{at}atlas.med.unlp.edu.ar ramattia{at}atlas.med.unlp.edu.ar

Objectives: Ca2+/calmodulin-dependent protein kinase II (CaMKII) has been implicated in the regulation of cardiac excitation–contraction coupling (ECC) as well as in apoptotic signaling and adverse remodeling. The goal of the present study is to investigate the role of CaMKII in irreversible ischemia and reperfusion (I/R) injury.

Methods: Isovolumic Langendorff perfused rat hearts were subjected to global no-flow I/R (45 min/120 min), and isolated myocytes were subjected to a protocol of simulated I/R (45 min simulated ischemia/60 min reoxygenation) either in the absence or presence of CaMKII inhibition [KN-93 (KN) or the CaMKII inhibitory peptide (AIP)].

Results: In I/R hearts, an increase in CaMKII activity at the beginning of reperfusion was confirmed by the significantly increased phosphorylation of the Thr17 site of phospholamban. In the presence of KN, contractile recovery at the end of reperfusion was almost double that of I/R hearts. This recovery was associated with a significant decrease in the extent of infarction, lactate dehydrogenase release (necrosis), TUNEL-positive cells, caspase-3 activity, and an increase in the Bcl-2/Bax ratio (apoptosis). In isolated myocytes, both KN and AIP prevented simulated I/R-induced spontaneous contractile activity and cell mortality. Similar results were obtained when inhibiting the reverse mode Na+/Ca2+ exchanger (NCX) with KB-R7943, sarcoplasmic reticulum (SR) function with ryanodine and thapsigargin, or SR Ca2+ release with tetracaine. In contrast, overexpression of CaMKII decreased cell viability from 52±3% to 26±2%.

Conclusions: Taken together, the present findings are the first to establish CaMKII as a fundamental component of a cascade of events integrating the NCX, the SR, and mitochondria that promote cellular apoptosis and necrosis in irreversible I/R injury.

KEYWORDS CaMKII; Ischemia/reperfusion injury; Apoptosis; Necrosis; Myocardium


1 Both authors contribute equally to this work.

Time for primary review 35 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.